Immunogenicity and safety of a new quadrivalent HPV vaccine in girls and boys aged 9–14 years versus an established quadrivalent HPV vaccine in women aged 15–26 years in India: a randomised, active-controlled, multicentre, phase 2/3 trial

Hitt Sharma, Sameer Parekh, Pramod Pujari, Sunil Shewale, Shivani Desai, Neerja Bhatla, Smita Joshi, Sharmila Pimple, Anand Kawade, Latha Balasubramani, Anitha Thomas, Vanita Suri, Sanjay Lalwani, Rajini Uday, Veena Kamath, Ranajit Mandal, A Rajeswar, Abraham Peedicayil, Usha Rani Poli, Dipanwita Banerjee, Rengaswamy Sankaranarayanan, Partha Basu, Richard Muwonge, Sunil Gairola, Vikas Dogar, Harish Rao, Umesh Shaligram